Scholl Hendrik Peter Insider Trades & Stock Holdings

Chief Medical Officer · Belite Bio, Inc · Latest filing Oct 1, 2026

Scholl Hendrik Peter, Chief Medical Officer at Belite Bio, Inc has 4 Form 4 trades on file since Jun 16, 2026. Open-market activity: 0 purchases ($0) and 4 sales ($4.35M), net -$4.35M. Latest filing: disposed of 500 shares of $BLTE on Oct 1, 2026 at $165.32.

Trades on file

4

Open-market bought

$0

Open-market sold

$4.35M

Net open-market

-$4.35M

Latest filing

Oct 1, 2026

All insider trades by Scholl Hendrik Peter

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 1, 2026	$BLTE	Sell (Open-market sale) 10b5-1	500	$165.32	$82.66K			-6.4%			Chief Medical Officer		—
Jun 18, 2026	$BLTE	Sell (Open-market sale)	10K	$145.24	$1.45M			+2.5%	+4.6%		Chief Medical Officer		Read
Jun 16, 2026	$BLTE	Sell (Open-market sale)	10K	$140.57	$1.41M			+5.0%	+9.0%		Chief Medical Officer		Read
Jun 16, 2026	$BLTE	Sell (Open-market sale)	10K	$140.57	$1.41M			+5.0%	+9.0%		Chief Medical Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Scholl Hendrik Peter traded

• $BLTE

Frequently asked questions

Has Scholl Hendrik Peter been buying or selling stock?

Scholl Hendrik Peter has 0 open-market purchases and 4 open-market sales on file, net -$4.35M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Scholl Hendrik Peter's latest insider trade?

disposed of 500 shares of $BLTE on Oct 1, 2026 at $165.32.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.